ISOCITRATE DEHYDROGENASE GENE MUTATION
Clinical trials for ISOCITRATE DEHYDROGENASE GENE MUTATION explained in plain language.
Never miss a new study
Get alerted when new ISOCITRATE DEHYDROGENASE GENE MUTATION trials appear
Sign up with your email to follow new studies for ISOCITRATE DEHYDROGENASE GENE MUTATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Experimental cancer drug halted in early testing phase
Disease control TerminatedThis early-stage study tested the safety and appropriate dosage of an experimental oral drug called HMPL-306 in people with advanced solid tumors that have a specific genetic change (IDH mutation). The trial enrolled 42 adults whose cancer had progressed after standard treatments…
Matched conditions: ISOCITRATE DEHYDROGENASE GENE MUTATION
Phase: PHASE1 • Sponsor: Hutchmed • Aim: Disease control
Last updated Apr 04, 2026 03:20 UTC
-
New pill tested for Tough-to-Treat blood cancers
Disease control TerminatedThis early-stage study tested an oral drug called HMPL-306 in adults with advanced blood cancers that had returned or stopped responding to other treatments. The main goals were to find a safe dose and see how the body processes the drug. The trial focused on patients whose cance…
Matched conditions: ISOCITRATE DEHYDROGENASE GENE MUTATION
Phase: PHASE1 • Sponsor: Hutchmed • Aim: Disease control
Last updated Apr 04, 2026 03:20 UTC